Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

Clinical trial NCT00156962 · TERMINATED

Trial details

NCT number: NCT00156962
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2005-04-01
Primary completion: 2007-03-01
Enrollment: 850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.